000 | 01486 a2200397 4500 | ||
---|---|---|---|
005 | 20250512200429.0 | ||
264 | 0 | _c19841219 | |
008 | 198412s 0 0 eng d | ||
022 | _a0033-3182 | ||
024 | 7 |
_a10.1016/S0033-3182(84)72962-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSwift, R M | |
245 | 0 | 0 |
_aEssential hypertension: psychiatric aspects and use of psychotropics. _h[electronic resource] |
260 |
_bPsychosomatics _cOct 1984 |
||
300 |
_a737-42, 745 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadverse effects |
650 | 0 | 4 |
_aAnalgesics _xpharmacology |
650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aDepressive Disorder _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacology |
650 | 0 | 4 |
_aLithium _xpharmacology |
650 | 0 | 4 | _aLithium Carbonate |
650 | 0 | 4 |
_aPsychotropic Drugs _xpharmacology |
650 | 0 | 4 |
_aReserpine _xadverse effects |
650 | 0 | 4 |
_aVasodilator Agents _xadverse effects |
700 | 1 | _aBlack, H R | |
773 | 0 |
_tPsychosomatics _gvol. 25 _gno. 10 _gp. 737-42, 745 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0033-3182(84)72962-8 _zAvailable from publisher's website |
999 |
_c6149676 _d6149676 |